Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2000
12/21/2000WO2000076516A1 Il-8 receptor antagonists
12/21/2000WO2000076515A1 Il-8 receptor antagonists
12/21/2000WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000076501A1 Il-8 receptor antagonists
12/21/2000WO2000076495A1 Il-8 receptor antagonists
12/21/2000WO2000076478A1 Controlled release and taste masking oral pharmaceutical compositions
12/21/2000WO2000076457A2 Il-8 receptor antagonists
12/21/2000WO2000076315A1 Transdermally delivered aspirin
12/21/2000WO2000076309A2 Non-human transgenic animals deficient in gas6 function and their use
12/21/2000WO2000066736B1 Growth factor homolog zvegf4
12/21/2000WO2000053628A3 Genes encoding human potassium channel proteins
12/21/2000WO2000047580A3 Phenyl urea and phenyl thiourea derivatives
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000WO2000045167A3 Non-invasive method for detecting target rna
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
12/21/2000WO2000044361A3 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
12/21/2000WO2000038660A3 Use of bisphosphonates for the prevention and treatment of infectious processes
12/21/2000WO2000031094A3 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
12/21/2000DE19928146A1 New 3-benzylamino-benzothienopyrimidine derivatives inhibit phosphodiesterase V and are useful for treating cardiac insufficiency and impotence
12/21/2000DE19927571A1 Increasing the levels of flavonoids and phenolic compounds in plants comprises treating the plants with growth-regulating 4-acyl-3,5-dioxo-1-cyclohexanecarboxylic acid derivatives
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2391361A1 47 human secreted proteins
12/21/2000CA2387696A1 48 human secreted proteins
12/21/2000CA2384339A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382769A1 42 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2382185A1 48 human secreted proteins
12/21/2000CA2377397A1 Il-8 receptor antagonists
12/21/2000CA2377395A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000CA2377391A1 Il-8 receptor antagonists
12/21/2000CA2377386A1 Il-8 receptor antagonists
12/21/2000CA2377341A1 Il-8 receptor antagonists
12/21/2000CA2377325A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000CA2377320A1 Methods for modulating fxr receptor activity
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2376715A1 Aminotetralin derivative for the therapy of cardiovascular diseases
12/21/2000CA2376630A1 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt
12/21/2000CA2376467A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
12/21/2000CA2375920A1 Compounds
12/21/2000CA2375878A1 Dithiepino[6,5-b]pyridines, and related compositions and methods
12/21/2000CA2375841A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000CA2340120A1 Transdermally delivered aspirin
12/20/2000EP1060188A1 Cholenic acid amides and pharmaceutical compositions thereof
12/20/2000EP1060182A2 Novel prodrugs for phosphorus-containing compounds
12/20/2000EP1060181A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
12/20/2000EP1060177A1 Method for producing doxazodin mesylate in a crystal modification designated as form a and intermediate product for producing the same
12/20/2000EP1060167A1 Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed et a?/et b?-receptor antagonists
12/20/2000EP1060166A1 Five-membered, benzo-condensed heterocycles used as antithrombotic agents
12/20/2000EP1060164A1 Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists
12/20/2000EP1060162A1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
12/20/2000EP1059940A2 Method for treating painful conditions of the anal region and compositions therefor
12/20/2000EP1059889A1 Treatment of brain edema using carbonic anhydrase enzyme inhibitor
12/20/2000EP1059843A1 Method for decreasing qt dispersion or inhibiting the progression of qt dispersion with an angiotensin ii receptor antagonist
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000EP0753526B1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient
12/20/2000EP0726898B1 Phenylindole compounds
12/20/2000EP0700378B1 Compounds which release nitric oxide
12/20/2000EP0543858B1 Benzimidazole derivatives, process for their preparation and application
12/20/2000CN1277634A New tissue-specific calpaines, their production and their use
12/20/2000CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
12/20/2000CN1277611A 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
12/20/2000CN1277604A Heteraryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/20/2000CN1277555A Composition for improving mental capabilities in mammals
12/20/2000CN1277262A Urokinase zymogen mutant
12/20/2000CN1277208A New angio-auxin derivative protein and its code sequence
12/20/2000CN1277198A New bicyclo aminopyrazineone compound, its producing process and medical composition containing them
12/20/2000CN1277037A Medicine for cardiac and cerebral vascular diseases and hypogona dism and its preparation
12/20/2000CN1277022A Medical composition for treating thrombus and its use
12/20/2000CN1059674C Hypolipidemic benzothiazepines
12/20/2000CN1059673C Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
12/20/2000CN1059580C Sikang yangsheng health-care tablet
12/19/2000US6162830 Antihistamines, antiallergens, bone disorders
12/19/2000US6162819 Pyrazole derivatives, their preparation and their use in pharmaceuticals
12/19/2000US6162818 Respiratory system disorders; crohn's disorder; cardiovascular disorders
12/19/2000US6162817 Stroke therapy; brain disorders; crohn's disease
12/19/2000US6162808 Compounds
12/19/2000US6162798 Cerebrovascular contraction after subarachnoid hemorrhage with quinoline compounds
12/19/2000US6162796 Method for transferring genes to the heart using AAV vectors
12/19/2000US6162790 Oligopeptides
12/19/2000US6162629 Preparing a serine protease solution; eluting protease from column, freeze drying, filtering and recovering protease
12/19/2000US6162463 Extended release formulation of diltiazem hydrochloride
12/19/2000US6162431 Serine/threonine protein kinase
12/19/2000CA2159787C Dibenzofuran aromatic derivatives; pharmaceutical and cosmetic compositions containing the same
12/19/2000CA2145881C Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
12/14/2000WO2000075329A1 Targeted angiogenesis
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075290A1 Method for multiplying stem cells
12/14/2000WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof
12/14/2000WO2000075187A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075174A1 Heart homing peptides and methods of using same
12/14/2000WO2000075172A2 FACTOR VIIa INHIBITORS
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075144A2 Peroxynitrite decomposition catalysts and methods of use thereof
1 ... 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 ... 1595